Free Trial

B. Metzler seel. Sohn & Co. AG Sells 4,404 Shares of Lam Research Corporation $LRCX

Lam Research logo with Computer and Technology background

Key Points

  • B. Metzler seel. Sohn & Co. AG reduced its stake in Lam Research Corporation by 3.2% in Q1, selling 4,404 shares to hold 132,365 shares valued at approximately $9.62 million.
  • Several hedge funds, including Ameriprise Financial Inc. and UBS AM, made significant adjustments to their holdings in Lam Research, indicating increased institutional interest in the company.
  • Lam Research reported a revenue of $5.17 billion for the quarter, surpassing analyst expectations, alongside an earnings per share of $1.33, exceeding the consensus estimate by $0.12.
  • MarketBeat previews the top five stocks to own by October 1st.

B. Metzler seel. Sohn & Co. AG lowered its stake in shares of Lam Research Corporation (NASDAQ:LRCX - Free Report) by 3.2% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 132,365 shares of the semiconductor company's stock after selling 4,404 shares during the quarter. B. Metzler seel. Sohn & Co. AG's holdings in Lam Research were worth $9,623,000 at the end of the most recent quarter.

Several other institutional investors have also bought and sold shares of LRCX. Vanguard Group Inc. grew its stake in Lam Research by 6.9% in the 1st quarter. Vanguard Group Inc. now owns 129,152,102 shares of the semiconductor company's stock valued at $9,389,358,000 after purchasing an additional 8,364,375 shares during the period. Ameriprise Financial Inc. grew its stake in Lam Research by 950.5% in the 4th quarter. Ameriprise Financial Inc. now owns 34,543,915 shares of the semiconductor company's stock valued at $2,495,128,000 after purchasing an additional 31,255,726 shares during the period. Invesco Ltd. grew its stake in Lam Research by 2.8% in the 1st quarter. Invesco Ltd. now owns 17,330,771 shares of the semiconductor company's stock valued at $1,259,947,000 after purchasing an additional 472,636 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its stake in Lam Research by 6,383.5% in the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 13,574,691 shares of the semiconductor company's stock valued at $980,500,000 after purchasing an additional 13,365,317 shares during the period. Finally, Janus Henderson Group PLC bought a new position in Lam Research in the 4th quarter valued at $792,161,000. Institutional investors own 84.61% of the company's stock.

Analysts Set New Price Targets

A number of research analysts have issued reports on the company. UBS Group upped their price objective on Lam Research from $95.00 to $120.00 and gave the company a "buy" rating in a research note on Monday, July 21st. Wall Street Zen upgraded Lam Research from a "hold" rating to a "buy" rating in a research note on Saturday, August 2nd. Citigroup increased their price target on Lam Research from $108.00 to $113.00 and gave the stock a "buy" rating in a research note on Friday, August 1st. Wells Fargo & Company set a $98.00 price target on Lam Research and gave the stock an "equal weight" rating in a research note on Thursday, July 31st. Finally, Mizuho increased their price target on Lam Research from $115.00 to $120.00 and gave the stock an "outperform" rating in a research note on Friday, August 1st. Twenty analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the company's stock. According to data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and a consensus price target of $107.30.

Read Our Latest Report on LRCX

Lam Research Price Performance

Shares of NASDAQ:LRCX traded down $3.94 on Monday, hitting $100.15. The company's stock had a trading volume of 12,177,963 shares, compared to its average volume of 11,266,383. The company has a 50-day simple moving average of $99.45 and a 200 day simple moving average of $85.31. Lam Research Corporation has a 1 year low of $56.32 and a 1 year high of $108.02. The company has a market capitalization of $126.75 billion, a PE ratio of 24.07, a PEG ratio of 1.29 and a beta of 1.76. The company has a debt-to-equity ratio of 0.38, a current ratio of 2.21 and a quick ratio of 1.55.

Lam Research (NASDAQ:LRCX - Get Free Report) last announced its quarterly earnings data on Wednesday, July 30th. The semiconductor company reported $1.33 earnings per share for the quarter, beating analysts' consensus estimates of $1.21 by $0.12. The company had revenue of $5.17 billion for the quarter, compared to analysts' expectations of $4.99 billion. Lam Research had a return on equity of 58.17% and a net margin of 29.07%.Lam Research's revenue for the quarter was up 33.6% compared to the same quarter last year. During the same period last year, the firm posted $1.03 EPS. Lam Research has set its Q1 2026 guidance at 1.100-1.300 EPS. Sell-side analysts forecast that Lam Research Corporation will post 3.71 EPS for the current fiscal year.

Lam Research Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, October 15th. Investors of record on Wednesday, September 24th will be issued a dividend of $0.26 per share. The ex-dividend date of this dividend is Wednesday, September 24th. This represents a $1.04 dividend on an annualized basis and a dividend yield of 1.0%. This is a positive change from Lam Research's previous quarterly dividend of $0.23. Lam Research's payout ratio is 22.12%.

About Lam Research

(Free Report)

Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products.

Featured Articles

Institutional Ownership by Quarter for Lam Research (NASDAQ:LRCX)

Should You Invest $1,000 in Lam Research Right Now?

Before you consider Lam Research, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Lam Research wasn't on the list.

While Lam Research currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

5 Hot Stocks to Buy Now: September’s Top Picks With Major Momentum
$15 Billion for Cybersecurity: The Government’s Next Big Push
Tesla’s Future Unleashed: Elon’s Robotics Move Changes Everything

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines